Europe's medicines watchdog partially approved a marketing request for a long-awaited new treatment for Alzheimer's disease ...
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, "Biogen") announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback